Article Cited by others

INVITED REVIEW

Glucocorticoids and prostate cancer treatment: friend or foe?

Montgomery Bruce, Cheng Heather H, Drechsler James, Mostaghel Elahe A

Year : 2014| Volume: 16| Issue : 3 | Page no: 354-358

   This article has been cited by
 
1 Mometasone furoate inhibits growth of acute leukemia cells in childhood by regulating PI3K signaling pathway
Xiaojing Wang,Jianli Shi,Deqiang Gong
Hematology. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Molecular underpinnings of enzalutamide resistance
S Prekovic,T Van den Broeck,S Linder,M E van Royen,A B Houtsmuller,F Handle,S Joniau,W Zwart,F Claessens
Endocrine-Related Cancer. 2018; 25(11): R545
[Pubmed]  [Google Scholar] [DOI]
3 Glucocorticoids Induce Stress Oncoproteins Associated with Therapy-Resistance in African American and European American Prostate Cancer Cells
Leanne Woods-Burnham,Christina K. Cajigas-Du Ross,Arthur Love,Anamika Basu,Evelyn S. Sanchez-Hernandez,Shannalee R. Martinez,Greisha L. Ortiz-HernŠndez,Laura Stiel,Alfonso M. DurŠn,Colwick Wilson,Susanne Montgomery,Sourav Roy,Carlos A. Casiano
Scientific Reports. 2018; 8(1)
[Pubmed]  [Google Scholar] [DOI]
4 Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer
Zhu Wang,Dinglan Wu,Chi-Fai Ng,Jeremy Yuen-Chun Teoh,Shan Yu,Yuliang Wang,Franky L Chan
Endocrine-Related Cancer. 2018; 25(1): 35
[Pubmed]  [Google Scholar] [DOI]
5 Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer
Jianneng Li,Mohammad Alyamani,Ao Zhang,Kai-Hsiung Chang,Michael Berk,Zhenfei Li,Ziqi Zhu,Marianne Petro,Cristina Magi-Galluzzi,Mary-Ellen Taplin,Jorge A Garcia,Kevin Courtney,Eric A Klein,Nima Sharifi
eLife. 2017; 6
[Pubmed]  [Google Scholar] [DOI]
6 Emerging aspects of microRNA interaction with TMPRSS2-ERG and endocrine therapy
Eugenio Zoni,Sofia Karkampouna,George N. Thalmann,Marianna Kruithof-de Julio,Martin Spahn
Molecular and Cellular Endocrinology. 2017;
[Pubmed]  [Google Scholar] [DOI]
7 Androgen deprivation by adrenal suppression using low-dose hydrocortisone for the treatment of breast carcinoma with apocrine features: a case report illustrating this new paradigm
Lynn Jongen,Robert Paridaens,Giuseppe Floris,Hans Wildiers,Patrick Neven
Breast Cancer Research and Treatment. 2016;
[Pubmed]  [Google Scholar] [DOI]
8 Managing Metastatic Castration-Resistant Prostate Cancer in the Pre-chemotherapy Setting: A Changing Approach in the Era of New Targeted Agents
Zafeiris Zafeiriou,Anuradha Jayaram,Adam Sharp,Johann S. de Bono
Drugs. 2016;
[Pubmed]  [Google Scholar] [DOI]
9 The role of glucocorticoid receptor in prostate cancer progression: from bench to bedside
Jieping Hu,Qingke Chen
International Urology and Nephrology. 2016;
[Pubmed]  [Google Scholar] [DOI]
10 Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer
Jan Kroon,Martin Puhr,Jeroen T Buijs,Geertje van der Horst,DaniŽlle M Hemmer,Koen A Marijt,Ming S Hwang,Motasim Masood,Stefan Grimm,Gert Storm,Josbert M Metselaar,Onno C Meijer,Zoran Culig,Gabri van der Pluijm
Endocrine-Related Cancer. 2016; 23(1): 35
[Pubmed]  [Google Scholar] [DOI]
11 Improving Taxane-Based Chemotherapy in Castration-Resistant Prostate Cancer
Jan Kroon,Sander Kooijman,Nam-Joon Cho,Gert Storm,Gabri van der Pluijm
Trends in Pharmacological Sciences. 2016;
[Pubmed]  [Google Scholar] [DOI]
12 WOMEN IN CANCER THEMATIC REVIEW: New roles for nuclear receptors in prostate cancer
Damien A Leach,Sue M Powell,Charlotte L Bevan
Endocrine-Related Cancer. 2016; 23(11): T85
[Pubmed]  [Google Scholar] [DOI]
13 AndrogenĖglucocorticoid interactions in the era of novel prostate cancer therapy
Sujata Narayanan,Sandy Srinivas,David Feldman
Nature Reviews Urology. 2015; 13(1): 47
[Pubmed]  [Google Scholar] [DOI]
14 Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects
R Ferraldeschi,J Welti,J Luo,G Attard,J S de Bono
Oncogene. 2015; 34(14): 1745
[Pubmed]  [Google Scholar] [DOI]
15 The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumors
Ning Xie,Helen Cheng,Dong Lin,Liangliang Liu,Ou Yang,Li Jia,Ladan Fazli,Martin E. Gleave,Yuzhuo Wang,Paul Rennie,Xuesen Dong
International Journal of Cancer. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]

 

Read this article